Ambloc

Quick links to important sections

Ambloc

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ambloc

Property Description
Active Ingredient Amlodipine
Form Oral Tablet
Pharmacological Class Calcium Channel Blocker (CCB)
General Purpose Antihypertensive and Antianginal agent
Origin Synthetic Compound (Dihydropyridine derivative)

What Type of Medicine is Ambloc?

Ambloc is a prescription-only medication whose active ingredient is Amlodipine, a substance classified as a Calcium Channel Blocker (CCB). Specifically, it is a dihydropyridine derivative used for the sustained management of cardiovascular conditions. This classification is broadly clinically recognized for its long-acting action on vascular smooth muscle. The drug's classification as a CCB is foundational to its established role as an antihypertensive agent, distinguishing it from other cardiovascular therapies like ACE inhibitors or diuretics.


Composition and Pharmaceutical Form

The medicine is supplied as a single-ingredient oral tablet designed for systemic administration throughout the body. The composition of Ambloc consists of the active substance, Amlodipine, which is typically synthesized as Amlodipine besylate, combined with inert pharmaceutical excipients necessary to form a stable, ingestible solid unit. Being an oral medication, it is engineered for slow release and long-acting effects, a key differentiating feature that supports the requirement for consistent therapeutic levels necessary for chronic maintenance therapy. Amlodipine acts primarily as a peripheral vasodilator, selectively relaxing blood vessels away from the heart.


General Therapeutic Purpose

The general purpose of Ambloc is to support the cardiovascular system by reducing the force and resistance encountered by the heart. It achieves this by promoting the widening, or vasodilation, of blood vessels, which in turn lowers the overall pressure in the systemic circulation. This action is designed to reduce the heart’s workload and, by relaxing the coronary arteries, helps to optimize blood flow and oxygen supply to the heart muscle itself. This effect positions the drug for its utility in providing sustained, foundational support for managing chronic cardiovascular needs, such as maintaining steady blood pressure levels over time.

Regulatory References

  1. Amlodipine: MedlinePlus Drug Information

What side effects are possible with Ambloc?

Possible Side Effects and Safety Information

Ambloc (Amlodipine) is generally well-tolerated, with most documented adverse reactions being mild to moderate in severity. Adverse events are officially categorized based on System Organ Class and approximate frequency.

Frequency Common Adverse Reactions (Incidence >1%)
Most Common Edema (swelling, often dose-related), Headache
Common Fatigue, Nausea, Abdominal Pain, Somnolence, Dizziness, Flushing, Palpitations

Serious adverse reactions, while uncommon, include the risk of symptomatic hypotension, particularly in patients with severe aortic stenosis. An increase in the frequency, severity, or duration of angina or an acute myocardial infarction may develop upon starting the medication or increasing the dosage, especially in individuals with severe obstructive coronary artery disease.

Postmarketing reports have noted rare but serious events such as allergic reactions (including angioedema and erythema multiforme), pancreatitis, and hepatic dysfunction (including jaundice and elevated liver enzymes).

Safety Restrictions and Population Considerations:

  • Contraindication: Known hypersensitivity to the drug is a contraindication.
  • Hepatic Impairment: Slow dosage titration is recommended for patients with severe hepatic impairment due to the drug's extensive liver metabolism.
  • Pediatric Use: Safety and effectiveness have not been established in patients under 6 years of age.
  • Nursing Mothers: Discontinuation of the drug is recommended when administering to a nursing mother.

Monitoring notes in official labeling emphasize observing for signs of hypotension and worsening cardiovascular status in susceptible patients.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Ambloc, which contains Amlodipine, is primarily characterized by the severe physiological consequences of excessive peripheral vasodilation. This may manifest as marked hypotension, which is a profound and sustained reduction in blood pressure. A possible consequence of this dramatic drop is reflex tachycardia, or a rapid heart rate, along with signs such as fainting or syncope.

When to Seek Urgent Medical Attention

In all cases of suspected overdose, it is mandated by regulatory bodies to seek immediate medical attention and contact emergency services. A massive overdose can lead to life-threatening conditions, including shock or potential fatal outcomes due to the severity of the hypotension.

Official Management and Monitoring

Management procedures, as described in regulatory documents, focus on providing active cardiovascular support. This includes measures such as elevating the extremities and the judicious administration of intravenous fluids. If hypotension remains unresponsive to these initial steps, the consideration of vasopressors may be necessary.

No specific antidote is explicitly known for Amlodipine overdose, and procedures like hemodialysis are not likely to be beneficial due to the drug's high plasma protein binding. Due to the long elimination half-life, extended clinical observation and active cardiac and respiratory monitoring are essential requirements.

Therapeutic Uses of Ambloc

Ambloc is used across domains where additional symptomatic support is needed, applied in settings marked by temporary physiological imbalance. The medicine is considered relevant for easing symptoms associated with conditions like high blood pressure (hypertension), chronic stable angina, and coronary artery disease (CAD). It provides supportive relief when symptoms interfere with routine activities. It assists with managing symptom clusters that may become intense or disruptive and contributes to improved comfort during periods of heightened symptoms.

“It supports the patient during difficult episodes by easing distress and assists with supporting general well-being during symptomatic phases.”


Quick Fact: Relief for Symptoms Related to Physical Discomfort

Ambloc is applied in scenarios where additional management of discomfort is required, relevant when symptoms become momentarily overwhelming. It is commonly used when symptoms interfere with daily functioning.

Eligibility and Restrictions for Use

The eligibility for using Ambloc (Amlodipine) is defined by official regulatory documents based on patient population and pre-existing health conditions.

Contraindications and Non-Eligibility

Ambloc is contraindicated and must not be used in patients with known hypersensitivity to Amlodipine or to other dihydropyridine derivatives. Use is also prohibited in patients experiencing severe hypotension, shock (including cardiogenic shock), or obstruction of the outflow tract of the left ventricle (e.g., severe aortic stenosis) [SmPC].

Age-Related Rules and Restrictions

  • Adults are approved for hypertension and angina indications.
  • Pediatric patients are eligible for treatment of hypertension starting at age 6 to 17 years.
  • Use in children under 6 years of age is not established and is not recommended.
  • Older adults (Geriatric): Use requires caution due to a greater frequency of decreased organ function.

Conditional Use Status

  • Hepatic Impairment: Use requires caution and slow titration due to a prolonged elimination half-life [FDA Label, SmPC].
  • Renal Impairment: No specific dosage adjustment is generally required by regulators.
  • Pregnancy/Lactation: Use is restricted to cases where there is no safer alternative and the benefit outweighs the risk; Amlodipine is excreted in breast milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Ambloc is defined by its extensive metabolism, primarily through the CYP3A4 enzyme, leading to two main classes of pharmacokinetic interactions. Co-administration with strong or moderate CYP3A4 inhibitors (e.g., Ketoconazole, Diltiazem) results in an officially documented increase in Ambloc's systemic exposure (AUC and Cmax). Conversely, concurrent use of CYP3A4 inducers (e.g., Rifampicin, St. John's Wort) may decrease plasma concentrations, potentially reducing efficacy.

Pharmacodynamic and Clearance Restrictions

Ambloc's blood pressure-lowering effect is officially defined as additive when combined with other antihypertensive agents, PDE5 inhibitors, or alcohol. Certain combinations carry specific restrictions: Ambloc co-administration requires a mandatory dose limitation for Simvastatin to 20 mg daily due to increased statin exposure. Furthermore, co-administration with intravenous Dantrolene is recommended to be avoided in susceptible patients.

Non-Medicinal and Population Notes

The product label states that Grapefruit or Grapefruit Juice is not recommended due to the potential to increase the drug's bioavailability. Clearance is officially noted as being decreased in patients with severe hepatic impairment, resulting in a prolonged half-life and increased systemic exposure (AUC).

Mechanism of Action

How Ambloc Works: The Mechanism of Action


Modulating Calcium Signaling in Artery Walls

Amlodipine functions as a targeted blocker of the L-type Voltage-Dependent Calcium Channel ( Ca v1.2) primarily situated on vascular smooth muscle cells (VSMCs). By inhibiting the influx of extracellular Ca^2+ through these channels, the drug modulates the excitation-contraction coupling process. This fundamental molecular action prevents the rise in intracellular calcium needed for muscle fiber shortening, resulting in vascular smooth muscle relaxation and reduction of systemic arterial resistance.


Decreasing Total Peripheral Resistance

The widespread relaxation of arterial walls causes a decrease in Total Peripheral Resistance (TPR). This systemic change is the key physiological consequence, as the sustained reduction in resistance simultaneously decreases the impedance to ventricular ejection (afterload). Furthermore, the mechanism extends to the coronary arteries, promoting their relaxation to increase the capacity for myocardial blood flow.


Sustained Mechanistic Activity

The drug’s high selectivity for vascular smooth muscle channels, coupled with its slow association and dissociation kinetics, contributes to a sustained and gradual channel blockade. This kinetic profile relates to the mechanism’s sustained duration of action and contributes to a smooth modification of vascular tone.

Dosage and Administration Information

How to Use Ambloc: Administration Guidelines

Ambloc (Amlodipine) is intended for oral administration as a tablet and is utilized for chronic, long-term maintenance therapy. The medicine is designed to be taken once daily (q.d.) at the same time each day to maintain consistent therapeutic levels.

Dosage and Frequency

The standard adult dosing schedule begins with an initial dose of 5 mg once daily. The typical maintenance dose range is 5 mg to 10 mg once daily, and the maximum dose for adults is 10 mg per day. For pediatric patients aged 6 to 17 years being treated for hypertension, the starting dose is 2.5 mg once daily, not to exceed 5 mg daily.

Administration Context and Adjustment

Ambloc tablets may be taken with or without food, providing flexibility in daily scheduling. When a dosage change is necessary, adjustments (titration) should typically proceed slowly over a period of 7 to 14 days to fully assess the response before increasing the dose.

Population-Specific Initial Dosing

Dose modifications are utilized for certain populations. Patients who are older adults or those with hepatic impairment (liver issues) should generally be started on a lower initial dose of 2.5 mg once daily. No initial dose adjustment is required for patients with renal impairment (kidney issues).

Handling Missed Doses

If an oral dose is missed, it should be taken as soon as possible on that same day. However, a double dose must not be taken to compensate for the missed one.

Recent Clinical Evidence

Research evidence / Overview of studies for Ambloc (Amlodipine)

The research foundation for Ambloc, whose active ingredient is Amlodipine, is based on official clinical evaluations for its studied uses in cardiovascular conditions. The evidence landscape includes high-quality Randomized Controlled Trials (RCTs) and systematic reviews that track physiological measures and long-term health outcomes.


Evidence for Use in Hypertension (High Blood Pressure)

The evidence for Ambloc relating to high blood pressure comes from a substantial number of large-scale studies. Research examined key biomarkers, specifically measurements of Systolic and Diastolic Blood Pressure (BP), which are outcomes related to systemic or functional imbalance. Long-term studies monitored adult populations for several years, tracking the long-term incidence of major cardiovascular events to see if data showed patterns related to the use of the medicine. Studies describe patterns observed in the adult populations in measures of serious cardiovascular events when compared to individuals receiving placebo.


Evidence for Use in Chronic Stable and Vasospastic Angina

Ambloc was studied for its use in chronic stable angina using short-term, controlled trials. These trials explored how symptoms evolved in the observed populations by measuring functional outcomes, such as patients' Exercise Time, and by tracking Angina Attack Frequency—outcomes related to physical discomfort. Evidence also contributes to the broader landscape for vasospastic angina. The studies for this specific condition typically involved smaller participant numbers and shorter follow-up durations.


What is Still Uncertain in the Research Landscape

While the evidence base for Ambloc is comprehensive for its primary adult indications, certain research limitation frames apply. The long-term event data gathered from trials in patients with Coronary Artery Disease excluded individuals with pre-existing, severe heart failure or significantly reduced cardiac function, meaning results apply only to the populations studied and do not provide insight for that specific high-risk subgroup. Additionally, data for certain pediatric age groups (below age six) and dosing levels remain insufficient.

Key Studies & References

  1. Amlodipine - StatPearls (Comprehensive review of Indications, Angina, and Coronary Artery Disease Evidence)
  2. Amlodipine - MedlinePlus Drug Information (Consolidating evidence for specific populations and age groups)

Frequently Asked Questions (FAQ)

Common questions about Ambloc (FAQ)


Q: How long does Ambloc typically take to show its full effect?

Ambloc begins working on the day it is taken. However, according to official product information, it usually takes about seven to eight days of consistent, once-daily dosing to reach steady-state plasma levels. This means the amount of medication in the blood has stabilized to support the drug's intended therapeutic effect.


Q: What are the most commonly reported side effects when first starting Ambloc?

Official regulatory documents note that common nervous system effects, such as headache, dizziness, and somnolence (drowsiness), are noted to occur especially at the beginning of the treatment period. This is typical as the body adjusts to the medication.


Q: What is the difference in action between Ambloc and other related medications?

Ambloc is officially classified as a dihydropyridine calcium channel blocker (CCB). This type of drug is known to work by promoting the relaxation and widening of the arteries away from the heart, a process called peripheral arterial vasodilation. This mechanism distinguishes it from other general classes of blood pressure medications.


Q: Can women who are pregnant or planning to be pregnant take Ambloc?

Regulatory documents state that use is restricted to cases where the medical benefit is considered to outweigh the potential risk, as safer alternatives may not be available. Official information also confirms that Amlodipine, the active ingredient, is known to be excreted in breast milk.


Q: Is Ambloc a brand name or a generic drug?

Ambloc is a product that contains the active substance Amlodipine. Amlodipine is the generic name for the drug and is widely manufactured and sold under various different brand names.


Q: Can Ambloc cause problems with concentration or focus?

Adverse reaction lists found in official labeling include common central nervous system effects such as dizziness, somnolence (drowsiness), and fatigue. Adverse reaction reports indicate that these effects may be associated with impaired ability to drive or use complex machinery.


Q: What patient population was Ambloc initially approved for?

Regulatory documentation indicates that the primary indications for which Ambloc was studied and subsequently approved relate to the treatment of hypertension (high blood pressure) and chronic stable and vasospastic angina in the adult population.


Q: Is Ambloc considered a preventative medication?

Official research evidence highlights that clinical studies tracked the long-term incidence of major cardiovascular events in populations with chronic conditions like hypertension or coronary artery disease. This research explores the drug’s potential patterns in managing overall cardiovascular risk over time.


Q: What is the difference between Ambloc and a generic equivalent?

Ambloc and its generic equivalents are required by regulatory agencies to contain the exact same active substance, Amlodipine. Generic medications must also demonstrate bioequivalence, meaning they act in the body in the same way as the brand-name drug.


Q: What is the significance of the long half-life of Ambloc?

The long half-life of Ambloc, which is cited in official pharmacokinetic data as being between 30 and 50 hours, is clinically important. This feature is noted as supporting the required once-daily dosing schedule and providing a sustained duration of therapeutic action.


Q: Can Ambloc cause changes in body weight?

According to official regulatory documents, both weight increase and weight decrease have been reported as adverse reactions. These reactions are generally classified as uncommon adverse reactions based on clinical data.


Q: Can Ambloc be taken alongside common over-the-counter pain relievers?

Regulatory information indicates that regular, long-term use of NSAID pain relievers (such as ibuprofen) has been associated with a reduction in Ambloc’s blood pressure lowering effect. In contrast, other pain relievers like acetaminophen (paracetamol) are generally not noted to cause this type of interaction.


Q: Is Ambloc safe to use if I am taking daily vitamin supplements?

Official guidance suggests that a healthcare professional be consulted about all vitamins, supplements, and herbal remedies before use. This is because non-prescription products may potentially cause unforeseen interactions that could affect how Ambloc works.


Q: Are there any physical signs that Ambloc is starting to work?

Official patient information often notes that for the treatment of high blood pressure, there are frequently no visible symptoms or noticeable signs that the medicine is working. The effect of the medication is confirmed through objective measures, such as monitoring blood pressure.


Q: Do the side effects of Ambloc usually go away after a few weeks?

Regulatory documents state that common adverse reactions like headache and dizziness occur “especially at the beginning of the treatment.” This suggests that common side effects may diminish as the body adjusts to the medication.


Q: Does taking Ambloc affect the results of any common lab tests?

Post-marketing reports summarized in official labeling have noted rare instances of clinically relevant abnormal changes in laboratory tests. These include problematic findings such as increased hepatic enzymes (liver markers) and hyperglycaemia (high blood sugar).

How should Ambloc be stored and disposed of?

The official storage and disposal profile for Ambloc tablets is governed by regulatory requirements designed to maintain product integrity and ensure public safety.

Storage Conditions

Requirement Official Regulatory Statement
Temperature Store at controlled room temperature (20^circC to 25^circC or 68^circF to 77^circF).
Protection Keep the container tightly closed and protect the tablets from light, heat, and moisture.
Prohibited The product must be kept from freezing.

Handling and Disposal

The tablets must be kept in their original container and stored out of the sight and reach of children and pets. For disposal, the regulatory preference is to utilize a drug take-back program. If a take-back option is unavailable, the unused or expired medication must be mixed with an undesirable substance (such as coffee grounds or dirt) and sealed in a container before being discarded in the household trash. The labeling must be checked for specific environmental instructions, and all personal information must be scratched out before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ambloc found in:

A-Z Index: